loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r1_cep_1999_193___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE (1)

filter

01 Adrenaline tartrate (1)

filter

01 Germany (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R1-CEP 1999-193 - Rev 02
Withdrawn by Holder
Chemical
2009-11-17
2022-11-30
254
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-193 - Rev 02 of Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De

Looking for Certificates of Suitability (CEPs) for R1-CEP 1999-193 - Rev 02 of Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De 1

20

Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Adrenaline tartrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-193 - Rev 02

This Chemical Type CEP, issued on November 17, 2009, remains in force until November 30, 2022, ensuring its reliability within the pharmaceutical industry.

Substance Number 254 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY